Request for Covid-19 Impact Assessment of this Report
The global Opioid Induced Constipation (OIC) Drugs market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on Drug Type, the report describes major products type share of regional market. Products mentioned as follows:
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Valeant Pharmaceuticals International
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Opioid Induced Constipation (OIC) Drugs Picture
1.1.2 Specifications
Table Product Specifications of Opioid Induced Constipation (OIC) Drugs
1.2 Market Segment
1.2.1 by Drug Type
Table Products Segment of Opioid Induced Constipation (OIC) Drugs
Table Global Opioid Induced Constipation (OIC) Drugs Market by Type, 2011-2022 (USD Million)
1.2.1.1 Lubiprostone
Table Lubiprostone Overview
1.2.1.2 Methyl Naltrexone Bromide
Table Methyl Naltrexone Bromide Overview
1.2.1.3 Naldemedine
Table Naldemedine Overview
1.2.1.4 Alvimopan
Table Alvimopan Overview
1.2.1.5 Others
Table Others Overview
1.2.2 by Application
Table Application Segment of Opioid Induced Constipation (OIC) Drugs
Table Global Opioid Induced Constipation (OIC) Drugs Market by Application, 2011-2022 (USD Million)
1.2.2.1 Hospital Pharmacies
Table Hospital Pharmacies Overview
1.2.2.2 Retail Pharmacies
Table Retail Pharmacies Overview
1.2.2.3 Online Pharmacies
Table Online Pharmacies Overview
1.2.3 by Regions
Table Global Opioid Induced Constipation (OIC) Drugs Market by Region, 2011-2022 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Opioid Induced Constipation (OIC) Drugs
2.2 Upstream
Table Cost of Opioid Induced Constipation (OIC) Drugs
Figure Manufacturing Process of Opioid Induced Constipation (OIC) Drugs
2.3 Market
2.3.1 SWOT
Figure SWOT of Opioid Induced Constipation (OIC) Drugs
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Opioid Induced Constipation (OIC) Drugs
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Opioid Induced Constipation (OIC) Drugs
3.4 Market Entry
Table Market Entry of Opioid Induced Constipation (OIC) Drugs
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Lubiprostone Market, 2013-2018
Figure Lubiprostone Market Size and Growth, 2015-2019 (USD Million)
Figure Lubiprostone Market Size and Growth, 2015-2019 (in Volume)
Table Lubiprostone CAGR by Revenue and Volume, 2015-2019
4.1.2 Methyl Naltrexone Bromide Market, 2013-2018
Figure Methyl Naltrexone Bromide Market Size and Growth, 2015-2019 (USD Million)
Figure Methyl Naltrexone Bromide Market Size and Growth, 2015-2019 (in Volume)
Table Methyl Naltrexone Bromide CAGR by Revenue and Volume, 2015-2019
4.1.3 Naldemedine Market, 2013-2018
Figure Naldemedine Market Size and Growth, 2015-2019 (USD Million)
Figure Naldemedine Market Size and Growth, 2015-2019 (in Volume)
Table Naldemedine CAGR by Revenue and Volume, 2015-2019
4.1.4 Alvimopan Market, 2013-2018
Figure Alvimopan Market Size and Growth, 2015-2019 (USD Million)
Figure Alvimopan Market Size and Growth, 2015-2019 (in Volume)
Table Alvimopan CAGR by Revenue and Volume, 2015-2019
4.1.5 Others Market, 2013-2018
Figure Others Market Size and Growth, 2015-2019 (USD Million)
Figure Others Market Size and Growth, 2015-2019 (in Volume)
Table Others CAGR by Revenue and Volume, 2015-2019
4.2 Market Forecast
4.2.1 Lubiprostone Market Forecast, 2020-2025
Figure Lubiprostone Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Lubiprostone Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Lubiprostone CAGR by Revenue and Volume, 2012-2024
4.2.2 Methyl Naltrexone Bromide Market Forecast, 2020-2025
Figure Methyl Naltrexone Bromide Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Methyl Naltrexone Bromide Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Methyl Naltrexone Bromide CAGR by Revenue and Volume, 2012-2024
4.2.3 Naldemedine Market Forecast, 2020-2025
Figure Naldemedine Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Naldemedine Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Naldemedine CAGR by Revenue and Volume, 2012-2024
4.2.4 Alvimopan Market Forecast, 2020-2025
Figure Alvimopan Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Alvimopan Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Alvimopan CAGR by Revenue and Volume, 2012-2024
4.2.5 Others Market Forecast, 2020-2025
Figure Others Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Others Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Others CAGR by Revenue and Volume, 2012-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Hospital Pharmacies Market, 2013-2018
Figure Hospital Pharmacies Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Hospital Pharmacies CAGR by Revenue and Volume, 2015-2019
5.1.2 Retail Pharmacies Market, 2013-2018
Figure Retail Pharmacies Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Retail Pharmacies CAGR by Revenue and Volume, 2015-2019
5.1.3 Online Pharmacies Market, 2013-2018
Figure Online Pharmacies Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Online Pharmacies CAGR by Revenue and Volume, 2015-2019
5.2 Market Forecast
5.2.1 Hospital Pharmacies Market Forecast, 2020-2025
Figure Hospital Pharmacies Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Hospital Pharmacies Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Hospital Pharmacies CAGR by Revenue and Volume, 2020-2025
5.2.2 Retail Pharmacies Market Forecast, 2020-2025
Figure Retail Pharmacies Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Retail Pharmacies Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Retail Pharmacies CAGR by Revenue and Volume, 2020-2025
5.2.3 Online Pharmacies Market Forecast, 2020-2025
Figure Online Pharmacies Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Online Pharmacies Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Online Pharmacies CAGR by Revenue and Volume, 2020-2025
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2015-2019
Figure Asia-Pacific Market Size and Growth, 2015-2019 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2015-2019 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2015-2019
Figure North America Market Size and Growth, 2015-2019 (USD Million)
Figure North America Market Size and Growth, 2015-2019 (in Volume)
Table North America CAGR by Revenue and Volume, 2015-2019
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2015-2019
Figure Europe Market Size and Growth, 2015-2019 (USD Million)
Figure Europe Market Size and Growth, 2015-2019 (in Volume)
Table Europe CAGR by Revenue and Volume, 2015-2019
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2015-2019
Figure South America Market Size and Growth, 2015-2019 (USD Million)
Figure South America Market Size and Growth, 2015-2019 (in Volume)
Table South America CAGR by Revenue and Volume, 2015-2019
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2015-2019
Figure Middle East & Africa Market Size and Growth, 2015-2019 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2015-2019 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2020-2025
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
6.2.2 North America Market Forecast, 2020-2025
Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table North America CAGR by Revenue and Volume, 2020-2025
6.2.3 Europe Market Forecast, 2020-2025
Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Europe CAGR by Revenue and Volume, 2020-2025
6.2.4 South America Market Forecast, 2020-2025
Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table South America CAGR by Revenue and Volume, 2020-2025
6.2.5 Middle East & Africa Market Forecast, 2020-2025
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
7 Market Competitive
7.1 Global Market by Vendors
Table Global Opioid Induced Constipation (OIC) Drugs Market by Vendors, 2015-2019 (in Volume)
Table Global Opioid Induced Constipation (OIC) Drugs Market Share by Vendors, 2015-2019 (USD Million)
Table Global Opioid Induced Constipation (OIC) Drugs Market Share by Vendors, 2015-2019 (in Volume)
7.2 Market Concentration
Figure Opioid Induced Constipation (OIC) Drugs Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 Ironwood Pharmaceuticals Inc
Table Ironwood Pharmaceuticals Inc Profile List
Table Microecological Modulator Operating Data of Ironwood Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 Daiichi Sankyo Co Ltd
Table Daiichi Sankyo Co Ltd Profile List
Table Microecological Modulator Operating Data of Daiichi Sankyo Co Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Pfizer
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 Progenics Pharmaceuticals Inc
Table Progenics Pharmaceuticals Inc Profile List
Table Microecological Modulator Operating Data of Progenics Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 Shionogi & Co., Ltd
Table Shionogi & Co., Ltd Profile List
Table Microecological Modulator Operating Data of Shionogi & Co., Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 Allergan Plc
Table Allergan Plc Profile List
Table Microecological Modulator Operating Data of Allergan Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 Nektar Therapeutics
Table Nektar Therapeutics Profile List
Table Microecological Modulator Operating Data of Nektar Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 Purdue Pharma
Table Purdue Pharma Profile List
Table Microecological Modulator Operating Data of Purdue Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.9 S.L.A. Pharma AG
Table S.L.A. Pharma AG Profile List
Table Microecological Modulator Operating Data of S.L.A. Pharma AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.10 Mundipharma International Limited
Table Mundipharma International Limited Profile List
Table Microecological Modulator Operating Data of Mundipharma International Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.11 Ono Pharmaceutical Co., Ltd
Table Ono Pharmaceutical Co., Ltd Profile List
Table Microecological Modulator Operating Data of Ono Pharmaceutical Co., Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.12 Takeda Pharmaceutical Company Limited
Table Takeda Pharmaceutical Company Limited Profile List
Table Microecological Modulator Operating Data of Takeda Pharmaceutical Company Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.13 Theravance Biopharma Inc
Table Theravance Biopharma Inc Profile List
Table Microecological Modulator Operating Data of Theravance Biopharma Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.14 Valeant Pharmaceuticals International
Table Valeant Pharmaceuticals International Profile List
Table Microecological Modulator Operating Data of Valeant Pharmaceuticals International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.15 Cosmo Pharmaceuticals SA
Table Cosmo Pharmaceuticals SA Profile List
Table Microecological Modulator Operating Data of Cosmo Pharmaceuticals SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.16 Daewoong Pharmaceutical
Table Daewoong Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Daewoong Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.17 C.B. Fleet Company
Table C.B. Fleet Company Profile List
Table Microecological Modulator Operating Data of C.B. Fleet Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.18 Sucampo Pharmaceuticals
Table Sucampo Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Sucampo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion
Table Product Specifications of Opioid Induced Constipation (OIC) Drugs
Table Products Segment of Opioid Induced Constipation (OIC) Drugs
Table Global Opioid Induced Constipation (OIC) Drugs Market by Type, 2011-2022 (USD Million)
Table Lubiprostone Overview
Table Methyl Naltrexone Bromide Overview
Table Naldemedine Overview
Table Alvimopan Overview
Table Others Overview
Table Application Segment of Opioid Induced Constipation (OIC) Drugs
Table Global Opioid Induced Constipation (OIC) Drugs Market by Application, 2011-2022 (USD Million)
Table Hospital Pharmacies Overview
Table Retail Pharmacies Overview
Table Online Pharmacies Overview
Table Global Opioid Induced Constipation (OIC) Drugs Market by Region, 2011-2022 (USD Million)
Table Cost of Opioid Induced Constipation (OIC) Drugs
Table Market Dynamics
Table Policy of Opioid Induced Constipation (OIC) Drugs
Table GDP of Major Countries
Table Technology of Opioid Induced Constipation (OIC) Drugs
Table Market Entry of Opioid Induced Constipation (OIC) Drugs
Table Lubiprostone CAGR by Revenue and Volume, 2015-2019
Table Methyl Naltrexone Bromide CAGR by Revenue and Volume, 2015-2019
Table Naldemedine CAGR by Revenue and Volume, 2015-2019
Table Alvimopan CAGR by Revenue and Volume, 2015-2019
Table Others CAGR by Revenue and Volume, 2015-2019
Table Lubiprostone CAGR by Revenue and Volume, 2012-2024
Table Methyl Naltrexone Bromide CAGR by Revenue and Volume, 2012-2024
Table Naldemedine CAGR by Revenue and Volume, 2012-2024
Table Alvimopan CAGR by Revenue and Volume, 2012-2024
Table Others CAGR by Revenue and Volume, 2012-2024
Table Hospital Pharmacies CAGR by Revenue and Volume, 2015-2019
Table Retail Pharmacies CAGR by Revenue and Volume, 2015-2019
Table Online Pharmacies CAGR by Revenue and Volume, 2015-2019
Table Hospital Pharmacies CAGR by Revenue and Volume, 2020-2025
Table Retail Pharmacies CAGR by Revenue and Volume, 2020-2025
Table Online Pharmacies CAGR by Revenue and Volume, 2020-2025
Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019
Table North America CAGR by Revenue and Volume, 2015-2019
Table Europe CAGR by Revenue and Volume, 2015-2019
Table South America CAGR by Revenue and Volume, 2015-2019
Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
Table North America CAGR by Revenue and Volume, 2020-2025
Table Europe CAGR by Revenue and Volume, 2020-2025
Table South America CAGR by Revenue and Volume, 2020-2025
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
Table Global Opioid Induced Constipation (OIC) Drugs Market by Vendors, 2015-2019 (in Volume)
Table Global Opioid Induced Constipation (OIC) Drugs Market Share by Vendors, 2015-2019 (USD Million)
Table Global Opioid Induced Constipation (OIC) Drugs Market Share by Vendors, 2015-2019 (in Volume)
Table Price Factors List
Table Ironwood Pharmaceuticals Inc Profile List
Table Microecological Modulator Operating Data of Ironwood Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Co Ltd Profile List
Table Microecological Modulator Operating Data of Daiichi Sankyo Co Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Progenics Pharmaceuticals Inc Profile List
Table Microecological Modulator Operating Data of Progenics Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shionogi & Co., Ltd Profile List
Table Microecological Modulator Operating Data of Shionogi & Co., Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Allergan Plc Profile List
Table Microecological Modulator Operating Data of Allergan Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Nektar Therapeutics Profile List
Table Microecological Modulator Operating Data of Nektar Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Purdue Pharma Profile List
Table Microecological Modulator Operating Data of Purdue Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table S.L.A. Pharma AG Profile List
Table Microecological Modulator Operating Data of S.L.A. Pharma AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mundipharma International Limited Profile List
Table Microecological Modulator Operating Data of Mundipharma International Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ono Pharmaceutical Co., Ltd Profile List
Table Microecological Modulator Operating Data of Ono Pharmaceutical Co., Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Pharmaceutical Company Limited Profile List
Table Microecological Modulator Operating Data of Takeda Pharmaceutical Company Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Theravance Biopharma Inc Profile List
Table Microecological Modulator Operating Data of Theravance Biopharma Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Valeant Pharmaceuticals International Profile List
Table Microecological Modulator Operating Data of Valeant Pharmaceuticals International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cosmo Pharmaceuticals SA Profile List
Table Microecological Modulator Operating Data of Cosmo Pharmaceuticals SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daewoong Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Daewoong Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table C.B. Fleet Company Profile List
Table Microecological Modulator Operating Data of C.B. Fleet Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sucampo Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Sucampo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...